Perceptive Advisors’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$697K Sell
139,667
-380,333
-73% -$1.9M 0.03% 75
2025
Q1
$4.17M Buy
+520,000
New +$4.17M 0.15% 69